Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities:
Net earnings	$ 1,229	$ 1,523
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	414	421
Stock-based compensation expense	271	262
Restructuring and other charges	134	341
Deferred taxes on earnings	0	(825)
Other, net	(13)	36
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(106)	426
Inventory	(678)	374
Accounts payable	360	(1,933)
Net investment in leases	(81)	(51)
Taxes on earnings	(128)	330
Restructuring and other	(144)	(167)
Other assets and liabilities	(556)	(117)
Net cash provided by operating activities	702	620
Cash flows from investing activities:
Investment in property, plant and equipment, net	(277)	(322)
Purchases of available-for-sale securities and other investments	0	(5)
Maturities and sales of available-for-sale securities and other investments	0	18
Collateral posted for derivative instruments	0	(127)
Payment made in connection with business acquisitions, net of cash acquired	0	(5)
Net cash used in investing activities	(277)	(441)
Cash flows from financing activities:
Payment of short-term borrowings with original maturities less than 90 days, net	0	(10)
Proceeds from debt, net of issuance costs	186	117
Payment of debt and associated costs	(102)	(587)
Stock-based award activities and others	(80)	(86)
Repurchase of common stock	(600)	(100)
Cash dividends paid	(544)	(518)
Collateral returned for derivative instruments	0	(200)
Net cash used in financing activities	(1,140)	(1,384)
Decrease in cash, cash equivalents and restricted cash	(715)	(1,205)
Cash, cash equivalents and restricted cash at beginning of period	3,232	3,145
Cash, cash equivalents and restricted cash at end of period	$ 2,517	$ 1,940